These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8589490)

  • 1. Supravenous hyperpigmentation in association with CHOP chemotherapy of a CD30 (Ki-1)-positive anaplastic large-cell lymphoma.
    Schulte-Huermann P; Zumdick M; Ruzicka T
    Dermatology; 1995; 191(1):65-7. PubMed ID: 8589490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disseminated strongyloidiasis and cytomegalovirus infection in a patient with anaplastic large cell lymphoma.
    Rehman JU; Rao TV; AlKindi S; Dennison D; Pathare AV
    Ann Hematol; 2007 Dec; 86(12):925-6. PubMed ID: 17641892
    [No Abstract]   [Full Text] [Related]  

  • 3. [Supportive care for patients with non-Hodgkin lymphoma receiving R-CHOP chemotherapy].
    Kato H
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():636-41. PubMed ID: 25831838
    [No Abstract]   [Full Text] [Related]  

  • 4. Cutaneous drug Reactions: Chemotherapy-induced hyperpigmentation.
    Hernández-Aragüés I; Baniandrés-Rodríguez O; Vilas-Boas PT; Conde-Montero E; Suárez-Fernández R
    Eur J Dermatol; 2017 Dec; 27(6):679-680. PubMed ID: 29311047
    [No Abstract]   [Full Text] [Related]  

  • 5. Ki-1-positive anaplastic large-cell lymphoma can mimic benign dermatoses.
    Camisa C; Helm TN; Sexton C; Tuthill R
    J Am Acad Dermatol; 1993 Nov; 29(5 Pt 1):696-700. PubMed ID: 8227541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHOP chemotherapy as standard therapy for treatment of patients with diffuse histiocytic lymphoma.
    Fisher RI
    Important Adv Oncol; 1990; ():217-25. PubMed ID: 2182520
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lingua villosa nigra after chemotherapy].
    Lkhoyaali S; Errihani H
    Pan Afr Med J; 2014; 18():69. PubMed ID: 25400836
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful treatment for recurrence of primary cutaneous anaplastic large-cell lymphoma in elderly patient with etoposide, mitoxantrone, cyclophosphamide, vincristine, prednisolone and bleomycin (VNCOP-B) therapy.
    Isogai R; Fukao M; Kawada A
    J Dermatol; 2007 Aug; 34(8):556-60. PubMed ID: 17683387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary CD30-positive anaplastic large cell lymphoma of the lip.
    Chim CS; Chan AC; Raymond L
    Oral Oncol; 1998 Jul; 34(4):313-5. PubMed ID: 9813729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinician's decision of whether CHOP chemotherapy should be standard therapy for treatment of patients with diffuse histiocytic lymphoma.
    Connors JM
    Important Adv Oncol; 1990; ():227-33. PubMed ID: 2182521
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclophosphamide-induced generalised reticulated skin pigmentation: a rare presentation.
    Youssef M; Mokni S; Belhadjali H; Aouem K; Moussa A; Laatiri A; Zili J
    Int J Clin Pharm; 2013 Jun; 35(3):309-12. PubMed ID: 23468078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous involvement in systemic anaplastic large cell lymphoma.
    Kwok C; Salmo E
    J Dtsch Dermatol Ges; 2015 Jul; 13(7):693-5. PubMed ID: 26031654
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of R-EPOCH and R-CHOP as a first-line regimen in de novo DLBCL patients with high Ki-67 expression in a single institution.
    Huang JJ; Xia Y; Wang Y; Liu PP; Bi XW; Sun P; Lin TY; Jiang WQ; Li ZM
    Oncotarget; 2016 Jul; 7(27):41242-41250. PubMed ID: 27183909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tongue and teeth hyperpigmentation in etoposide, prednisolone, vincristine, and cyclophosphamide regimen in the treatment of cutaneous lymphoma.
    Morabad SS; Khan ZU; Gad R; Kallur N; Madhabhavi IV; Shalavadi MH; Mangannavar CV
    Indian J Pharmacol; 2023; 55(6):405-407. PubMed ID: 38174538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pancytopenia after viral infection in St. n. malignant lymphoma].
    Seifert B; Favre G
    Praxis (Bern 1994); 2003 Jan; 92(4):143-6. PubMed ID: 12632845
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of age group on febrile neutropenia risk assessment and management in patients with diffuse large B-cell lymphoma treated with R-CHOP regimens.
    Lugtenburg P; Silvestre AS; Rossi FG; Noens L; Krall W; Bendall K; Szabo Z; Jaeger U
    Clin Lymphoma Myeloma Leuk; 2012 Oct; 12(5):297-305. PubMed ID: 23040435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary cutaneous CD30 (Ki-1)-positive non-anaplastic B-cell lymphoma.
    Herrera E; Gallardo M; Bosch R; Cabra B; Aneri V; Sánchez P
    J Cutan Pathol; 2002 Mar; 29(3):181-4. PubMed ID: 11972717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized study comparing doxorubicin, cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (ACOMLA) with cyclophosphamide, doxorubicin, vincristine, prednisone, and bleomycin (CHOP-B) in the treatment of diffuse histiocytic lymphoma.
    Newcomer LN; Cadman EC; Nerenberg MI; Chen M; Bertino JR; Farber LR; Prosnitz LR
    Cancer Treat Rep; 1982 Jun; 66(6):1279-84. PubMed ID: 6177407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.
    Fisher RI; Gaynor ER; Dahlberg S; Oken MM; Grogan TM; Mize EM; Glick JH; Coltman CA; Miller TP
    N Engl J Med; 1993 Apr; 328(14):1002-6. PubMed ID: 7680764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic, cytogenetic, and molecular studies of 13 Chinese Patients with Ki-1 anaplastic large cell lymphoma. Special emphasis on the tumor response to 13-cis retinoic acid.
    Chou WC; Su IJ; Tien HF; Liang DC; Wang CH; Chang YC; Cheng AL
    Cancer; 1996 Oct; 78(8):1805-12. PubMed ID: 8859196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.